Appendix 3Y Change of Director’s Interest Notice + See chapter 19 for defined terms. Appendix 3Y Page 1 Rule 3.19A.2 Appendix 3Y Change of Director’s Interest Notice Information or documents not available now must be given to ASX as soon as available. Information and documents given...
Appendix 3Y-Dr Geoffrey Brooke
Filed with ASX · · 2 pages · English
Release
Actinogen Medical Limited on 6ix
Earlier from Actinogen Medical
- Application for quotation of securities - ACW
- ACW CMO international Xanamem presentation
- Response to ASX Price Query
- ACW unlisted options fully underwritten
- Proposed issue of securities - ACW
Later from Actinogen Medical
- Notification of cessation of securities - ACW
- ACW Alzheimers pivotal trial completes last patient visit
- Options underwriting cleansing notice
- Underwriting of unlisted options completed
- Actinogen XanaMIA pivotal Alzheimer’s disease trial completes final patient visit, with topline results on track for November
Follow Actinogen Medical into a list and get an email when it puts out news.
Follow Actinogen Medical